The above chart presents the market trend analysis for gufic stridden biopharma pvt ltd. from 2021 to 2022.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2022, the company has completed 2 transactions, with a transaction quantity of 0 and a transaction weight of 887.81.
YearTransactionsQuantityWeight
20211297466955
202220887.81
Bill of lading data
<
1/15
>
Trade date
2022/03/20
B/L No.
21790956471
Suppliers
gufic stridden biopharma pvt ltd.
Buyers
suhitas pharmaceutical inc.
gufic stridden biopharma pvt ltd. is india Supplier,
and primarily engages in the import and export business of products such as pantoprazole,omeprazole,pantonix.
According to the 52wmb.com global trade database, as of 2022-03-20, the company has completed 1054 international trades,
with its main trading regions covering kenya,burma,sri lanka etc.
The core products include HS30049034,HS30049039,HS30049099000 etc,
often transported via sahar air cargo acc inbom4,port nhava sheva sea innsa1, port nhavasheva innsa1 etc,
and its main trading partners are sunpar pharmaceticals ltd.,life line co.ltd.,slim pharmaceuticals pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on gufic stridden biopharma pvt ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.